RAD December 2023 Abstracts and Posters
All accepted abstracts have been publised in The British Journal of Dermatology. You may access the publication at: https://academic.oup.com/bjd/issue/188/1539 - Baseline patient characteristics, physician-assessed effectiveness, patient-reported outcomes, and safety in adult atopic dermatitis patients in Japan treated with dupilumab: Real-world insights one year into the GLOBOSTAD multinational prospective observational study
Hilde Lapeere, Yoko Kataoka, Shintaro Takeoka, Yayoi Tada, Hidetoshi Takahashi, Akiko Yagami, Jiangming Wu, Marius Ardeleanu, Kwinten Bosman
541 - Real-world effectiveness of dupilumab in adult and adolescent patients with atopic dermatitis: 3-year data from the PROSE registry
Eric L. Simpson, Ben Lockshin, Lara Wine Lee, Liyang Shao, Bengisu Ozarslan, Andrew Korotzer
542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis
Jonathan I. Silverberg, Sonja Ständer, Brian S. Kim, Anthony Bewley, Laurent Misery, Christian Vestergaard, Melinda J. Gooderham, Andrew G. Bushmakin, Joseph C. Cappelleri, Erman Güler, Justine Alderfer, Melissa Watkins, Andrew Selfridge, Daniela E. Myers
544 - Cost-per-responder analysis of tralokinumab versus dupilumab in patients with moderate-to-severe atopic dermatitis in the US and Canada
Jashin J. Wu, Sanjeev Balu, Nikolaj Birk Larsen, Ryan Pulleyblank, Liv Strømkjær, Aron Quah, Marni Wiseman
545 - Prevalence of moderate and severe atopic dermatitis in Ireland: A cross-sectional, real-world study of a secondary care population.
Oisín Shane Gough; Fiona McEvoy; Michael O’Connell; Maeve Lynch, Brian Kirby, Michelle Murphy
546 - Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment
Steven R. Feldman, Annie Guerin, Marjolaine Gauthier-Loiselle, Nisha C Hazra, Yan Meng, Kirsten Gallant, Ami J Claxton, Sanjeev Balu
547 - Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States
Steven R. Feldman, Annie Guerin, Marjolaine Gauthier-Loiselle, Ami J Claxton, Nisha C Hazra, Yan Meng, Kirsten Gallant, Sanjeev Balu
548 - Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities
Amy S. Paller, Weily Soong, Mark Boguniewicz, Bob Geng, Jacob P. Thyssen, Aldana Rosso, Louise Steffensen, Shannon Schneider, Andreas Wollenberg
549 - Laboratory parameters in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial
Amy Paller, Michael Cork, Chih-ho Hong, Weily Soong, Shannon Schneider, Hannah Lo, Line Rosendahl Meldgaard Pedersen, Emilia Vacko6, Andreas Wollenberg
551 - Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control
Andrew Blauvelt, Richard G Langley, Ketty Peris, Juan Francisco Silvestre, Norito Katoh, Marie Tauber, Andreas Pinter, Mahreen Ameen, Melinda Gooderham, Christian Bjerregård Øland, Ann-Marie Tindberg, Le Gjerum, Kristian Reich